Literature DB >> 14640536

Molecular basis of neurotrophin-receptor interactions.

Mookda Pattarawarapan1, Kevin Burgess.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14640536     DOI： 10.1021/jm030221q

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  18 in total

1.  Universal peptidomimetics.

Authors:  Eunhwa Ko; Jing Liu; Lisa M Perez; Genliang Lu; Amber Schaefer; Kevin Burgess
Journal:  J Am Chem Soc       Date:  2010-12-23       Impact factor: 15.419

2.  Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor.

Authors:  M Cazorla; J M Arrang; J Prémont
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  Discovery of Disubstituted Imidazo[4,5-b]pyridines and Purines as Potent TrkA Inhibitors.

Authors:  Tao Wang; Michelle L Lamb; Michael H Block; Audrey Molina Davies; Yongxin Han; Ethan Hoffmann; Stephanos Ioannidis; John A Josey; Zhong-Ying Liu; Paul D Lyne; Terry MacIntyre; Peter J Mohr; Charles A Omer; Tove Sjögren; Kenneth Thress; Bin Wang; Haiyun Wang; Dingwei Yu; Hai-Jun Zhang
Journal:  ACS Med Chem Lett       Date:  2012-07-26       Impact factor: 4.345

4.  Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice.

Authors:  Maxime Cazorla; Joël Prémont; Andre Mann; Nicolas Girard; Christoph Kellendonk; Didier Rognan
Journal:  J Clin Invest       Date:  2011-04-18       Impact factor: 14.808

5.  Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice.

Authors:  Maxime Cazorla; Anne Jouvenceau; Christiane Rose; Jean-Philippe Guilloux; Catherine Pilon; Alex Dranovsky; Joël Prémont
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

6.  Directed evolution of brain-derived neurotrophic factor for improved folding and expression in Saccharomyces cerevisiae.

Authors:  Michael L Burns; Thomas M Malott; Kevin J Metcalf; Benjamin J Hackel; Jonah R Chan; Eric V Shusta
Journal:  Appl Environ Microbiol       Date:  2014-07-11       Impact factor: 4.792

Review 7.  Chiral kinase inhibitors.

Authors:  Jian-kang Jiang; Min Shen; Craig J Thomas; Mathew B Boxer
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 8.  Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.

Authors:  Igor Khalin; Renad Alyautdin; Ganna Kocherga; Muhamad Abu Bakar
Journal:  Int J Nanomedicine       Date:  2015-04-30

9.  Interaction between a Novel Oligopeptide Fragment of the Human Neurotrophin Receptor TrkB Ectodomain D5 and the C-Terminal Fragment of Tetanus Neurotoxin.

Authors:  Ana Candalija; Thomas Scior; Hans-Richard Rackwitz; Jordan E Ruiz-Castelan; Ygnacio Martinez-Laguna; José Aguilera
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

10.  From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF).

Authors:  Claire Géral; Angelina Angelova; Sylviane Lesieur
Journal:  Pharmaceutics       Date:  2013-02-08       Impact factor: 6.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.